New funding guidelines on therapeutics against SARS-CoV-2

The German Federal Ministry of Education and Research (BMBF) has released a new funding guideline to support research and development of urgently needed therapeutics against SARS-CoV-2.

The funding measure aims to strengthen the clinical development of promising therapeutic approaches against COVID-19. In this way, preclinically successfully tested candidates for new therapeutics should reach patients as quickly as possible and the treatment repertoire against COVID-19 should be expanded as needed. The purpose of the funding is the clinical development of drug candidates that are explicitly directed against SARS-CoV-2. Further information and contact details of the project executing organization can be found at:

Applications for funding can be submitted from now until February 17, 2021. The application process is single-stage.

A virtual information event will be held on February 01, 2021. Further information and the possibility to register can be found on the following website:


This Website uses Cookies

We store technically necessary cookies, without which the operation of the site is not possible. In order to provide you with a better user experience on our website, we would also like to evaluate anonymous analysis data. Which tools we use for this purpose and further information can be found in our Privacy Policy and in our Legal Notice.

Accept technically required cookies only

On our website you will find interesting videos and maps hosted on YouTube/Google Maps. The videos and maps are used without a cookie, but data is still loaded from google servers, which means that your surfing behaviour can be recorded by Google.

Name Google Analytics
Anbieter Google LLC
Zweck Cookie von Goolge für Website-Analysen, mit dem statistische und anonymisierte Daten darüber erfasst werden, wie der Besucher die Website nutzt.
Cookie Name _ga,_gat,_gid
Cookie Laufzeit 14 Monate